CA2673193C - Homogeneous paste and gel formulations - Google Patents

Homogeneous paste and gel formulations Download PDF

Info

Publication number
CA2673193C
CA2673193C CA2673193A CA2673193A CA2673193C CA 2673193 C CA2673193 C CA 2673193C CA 2673193 A CA2673193 A CA 2673193A CA 2673193 A CA2673193 A CA 2673193A CA 2673193 C CA2673193 C CA 2673193C
Authority
CA
Canada
Prior art keywords
veterinary
pharmaceutical
paste
paragraph
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2673193A
Other languages
English (en)
French (fr)
Other versions
CA2673193A1 (en
Inventor
Hassan Nached
Keith Freehauf
Peter Hanson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Merial LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/048672 external-priority patent/WO2007075827A2/en
Priority claimed from US11/713,881 external-priority patent/US20080027011A1/en
Application filed by Merial LLC filed Critical Merial LLC
Publication of CA2673193A1 publication Critical patent/CA2673193A1/en
Application granted granted Critical
Publication of CA2673193C publication Critical patent/CA2673193C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA2673193A 2006-12-19 2007-12-19 Homogeneous paste and gel formulations Active CA2673193C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
PCT/US2006/048672 WO2007075827A2 (en) 2005-12-20 2006-12-19 Homogeneous paste formulations
USPCT/US2006/048672 2006-12-19
US11/713,881 US20080027011A1 (en) 2005-12-20 2007-03-05 Homogeneous paste and gel formulations
US11/713,881 2007-03-05
PCT/US2007/088225 WO2008077130A2 (en) 2006-12-19 2007-12-19 Homogeneous paste and gel formulations

Publications (2)

Publication Number Publication Date
CA2673193A1 CA2673193A1 (en) 2008-06-26
CA2673193C true CA2673193C (en) 2014-08-05

Family

ID=40984939

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2673193A Active CA2673193C (en) 2006-12-19 2007-12-19 Homogeneous paste and gel formulations

Country Status (4)

Country Link
EP (1) EP2101736A4 (de)
CA (1) CA2673193C (de)
MX (1) MX2009006656A (de)
WO (1) WO2008077130A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10137111B2 (en) 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions
WO2019141771A1 (en) * 2018-01-18 2019-07-25 Zoetis Broomhill Ip Limited Internal teat sealants and their use in the prevention of bovine mastitis in the dry cow
US10857151B1 (en) * 2020-02-21 2020-12-08 Villya LLC Treatment of female genital schistosomiasis
US20220047506A1 (en) 2020-08-12 2022-02-17 Villya LLC Praziquantel Formulations
WO2024158694A1 (en) 2023-01-23 2024-08-02 Villya LLC Compositions and methods for improving the solubility of erectile dysfunction therapeutics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
WO2005063184A1 (en) * 2003-12-22 2005-07-14 Imrex, Inc. Methods and compositions for oral hygiene
ES2490595T3 (es) * 2005-02-17 2014-09-04 Abbott Laboratories Administración transmucosal de composiciones de fármacos para tratar y prevenir trastornos en animales

Also Published As

Publication number Publication date
WO2008077130A2 (en) 2008-06-26
MX2009006656A (es) 2009-08-07
EP2101736A4 (de) 2012-09-19
WO2008077130A3 (en) 2008-08-21
EP2101736A2 (de) 2009-09-23
CA2673193A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
US20080027011A1 (en) Homogeneous paste and gel formulations
ES2743673T3 (es) Composiciones parasiticidas orales veterinarias que comprenden agentes activos de acción sistémica, procedimientos y usos de las mismas
JP2005533806A (ja) 駆虫性動物用均質経口ペースト
RU2002124584A (ru) Фармацевтические и ветеринарные пастообразные композиции
US20170354593A1 (en) Palatable chewable veterinary composition
CA2673193C (en) Homogeneous paste and gel formulations
CA2634394C (en) Homogeneous paste formulations
CA2630458C (en) Benzimidazole non-aqueous compositions
BR112020010291A2 (pt) composição contendo moxidectina para tratamento de infestações de parasitas
AU2007100254A4 (en) Improved parasiticide paste
MX2008003516A (es) Formulaciones antihelminticas.
WO2026041786A1 (en) Injectable veterinary composition and uses thereof
AU2003238245B2 (en) Anthelmintic oral homogeneous veterinary pastes
HK1121343B (en) Homogeneous paste formulations
BR102013017846A2 (pt) Nanoformulações e submicroformulações com ativos ultraconcentrados com dendrímeros a base de antiespasmódicos e/ou aines (anti-inflamatórios não hormonais) e/ou anti-histamínicos ou aies (anti-inflamatórios hormonais) e/ou ciclosporinas com a finalidade de redimir sintomas de inflamações, cólicas, pruridos e dor em bovinos, suínos, caprinos, ovinos, caninos e felinos ou benzoil uréia e/ou acil uréia e/ou avermectinas isoladamente ou combinada com vermífugo e/ou inseticidas para o controle e prevenção de endo e ectoparasitas em bovinos, suínos, caprinos, ovinos, caninos, felinos e aves

Legal Events

Date Code Title Description
EEER Examination request